MetaCap

Electra Therapeutics (ETRA) vs Shattuck Labs (STTK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Electra Therapeutics is the larger company by market cap ($574.9 million vs $567.6 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ETRA-30.87%STTK-5.91%
+16%-9%-33%
Sep 18, 20261 yearOct 7, 2026
ETRA-30.87%STTK-5.91%
+14%-9%-33%
Sep 14, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ETRA versus STTK key metrics
MetricETRASTTK
Share price$9.16$5.66
Market cap$574.95M$567.55M
1-day change-6.72%-3.50%
YTD return—+54.93%
1-year return—+130.82%
5-year return—-70.74%
EPS (TTM)$-2.65$-0.45
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$15.50$8.33
52-week low$8.92$1.70
Distance from 52-week high-40.90%-32.11%
Analyst consensus—strong_buy
Avg. price target upside—+169.14%
Average volume990.55K1.20M
Shares outstanding62.77M100.36M
Employees4640
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Electra Therapeutics

ETRA stock →

Electra Therapeutics, Inc. is a clinical-stage biotechnology company.

Healthcare · Biotechnology · 46 employees

About Shattuck Labs

STTK stock →

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study.

Healthcare · Biotechnology · 40 employees

ETRA vs STTK FAQ

Which is bigger, Electra Therapeutics or Shattuck Labs?

Electra Therapeutics (ETRA) is larger, with a market capitalization of $574.95M compared with $567.55M for Shattuck Labs (STTK).

Are Electra Therapeutics and Shattuck Labs in the same industry?

Yes. Both are classified in the Biotechnology industry within the Healthcare sector.

More comparisons